CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 18,000 shares at $1.08 ($19,438)
- 4 Open-market buy Chief Financial Officer bought 4,348 shares at $1.15 ($4,978)
- 4 Open-market buy Chief Business Officer bought 65,218 shares at $1.15 ($74,675)
- 4 Open-market buy President and CEO bought 21,740 shares at $1.15 ($24,892)
- 8-K Event Material agreement · Regulation FD disclosure
- 424B4 Offering Prospectus
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
Page 19 of 61 · 1,218 filings